Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • ...rgic sympathetic nerves. Included here are drugs that directly stimulate [[adrenergic receptor]]s and drugs that act indirectly by provoking the release of adrenergic tra
    315 bytes (39 words) - 18:04, 14 May 2010
  • ...ic nervous system]]. Beta-2 adrenergic receptors are a "subclass of beta-[[adrenergic receptor]]s (receptors, adrenergic, beta). Beta-2 Adrenergic receptors are more sen
    1 KB (147 words) - 06:58, 14 September 2013
  • [[Adrenergic agonist]]s are "drugs that bind to and activate [[adrenergic receptor]]s."<ref name="MeSH - Adrenergic agonists">{{MeSH|Adrenergic agonists}}</re
    1 KB (159 words) - 04:09, 30 September 2009
  • {{r|Adrenergic receptor}}
    170 bytes (19 words) - 06:58, 17 October 2010
  • #Redirect [[Adrenergic receptor]]
    33 bytes (3 words) - 07:58, 20 May 2008
  • {{r|Adrenergic receptor}}
    307 bytes (32 words) - 06:55, 17 October 2010
  • {{r|Adrenergic receptor}}
    638 bytes (62 words) - 07:54, 17 October 2010
  • {{r|Adrenergic receptor}}
    1 KB (165 words) - 08:37, 18 June 2008
  • ...gic sympathetic nerves. Included here are drugs that directly stimulate [[adrenergic receptor]]s and drugs that act indirectly by provoking the release of adrenergic tra
    702 bytes (84 words) - 09:47, 4 March 2010
  • {{r|Adrenergic receptor}}
    576 bytes (72 words) - 16:44, 11 January 2010
  • ...adrenergic blockers''' are "drugs that bind to but do not activate alpha-[[adrenergic receptor]]s thereby blocking the actions of endogenous or exogenous adrenergic agoni Naftopidil is more selective for the alpha-1a [[adrenergic receptor]] and has been used to treat [[benign prostatic hyperplasia]].<ref name="pm
    2 KB (288 words) - 11:04, 11 June 2010
  • {{r|Adrenergic receptor}}
    586 bytes (72 words) - 07:42, 8 January 2010
  • {{r|Adrenergic receptor}}
    553 bytes (67 words) - 19:16, 11 January 2010
  • * beta-[[adrenergic receptor]] kinases ...inase subtype that has specificity for the agonist-occupied form of beta-[[adrenergic receptor]]s. It may play an essential role in regulating myocardial contractile resp
    5 KB (679 words) - 09:15, 29 August 2009
  • {{r|Adrenergic receptor}}
    616 bytes (75 words) - 16:49, 11 January 2010
  • {{r|Adrenergic receptor}}
    810 bytes (102 words) - 07:45, 8 January 2010
  • ...idodrina or midodrinum, is an ethanolamine derivative that is an alpha-1 [[adrenergic receptor]] agonist used as a vasoconstrictor agent in the treatment of [[hypotension ...one and elevates the blood pressure. It does not stimulate cardiac beta-[[adrenergic receptor]]s.
    2 KB (246 words) - 08:34, 8 June 2009
  • # [[G-protein-coupled receptor]]. Examples include [[adrenergic receptor]]s, [[angiotensin receptor]]s, [[bradykinin receptor]]s, [[CCR5 receptor]]
    2 KB (273 words) - 11:27, 4 May 2010
  • ...13">{{cite journal |author=Zaugg M, Bestmann L, Wacker J, ''et al'' |title=Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascu
    2 KB (313 words) - 14:09, 4 July 2009
  • Examples of G-protein-coupled receptors include [[adrenergic receptor]]s, [[angiotensin receptor]]s, [[bradykinin receptor]]s, [[CCR5 receptor]]
    3 KB (338 words) - 13:08, 30 March 2010
  • {{r|Adrenergic receptor}}
    898 bytes (111 words) - 19:11, 11 January 2010
  • ===Adrenergic receptor=== {{main|adrenergic receptor}}
    6 KB (767 words) - 17:34, 10 February 2024
  • {{r|Adrenergic receptor}}
    1 KB (161 words) - 10:26, 8 April 2023
  • {{r|Adrenergic receptor}}
    490 bytes (62 words) - 18:32, 11 January 2010
  • {{r|Adrenergic receptor}}
    537 bytes (69 words) - 11:56, 11 January 2010
  • ...thmias. [[Adrenergic beta-antagonist]]s that are selective for the beta-1 adrenergic receptor may be better for patients at risk of stroke.<ref name="pmid21795649">{{cit [[Beta-2 adrenergic receptor]]s are a "subclass of beta-adrenergic receptors (receptors, adrenergic, bet
    12 KB (1,491 words) - 23:11, 12 October 2011
  • {{r|Adrenergic receptor}}
    611 bytes (78 words) - 19:27, 11 January 2010
  • ...Pharmacological Basis of Therapeutics |edition=11th |chapter=α2-Selective Adrenergic Receptor Agonists |chapterurl=http://www.accessmedicine.com/content.aspx?aID=936531
    1 KB (180 words) - 15:55, 31 January 2009
  • * [[Adrenergic receptor]]
    1 KB (183 words) - 09:40, 23 January 2008
  • * [[Adrenergic receptor]]
    7 KB (963 words) - 08:11, 15 March 2024
  • In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
    1 KB (142 words) - 11:47, 2 February 2023
  • In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
    1 KB (142 words) - 14:35, 2 February 2023
  • {{r|Adrenergic receptor}}
    890 bytes (140 words) - 01:20, 25 June 2008
  • ...nvironmental chemicals, such as debrisoquine; [[Adrenergic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This enzyme is deficient
    3 KB (483 words) - 17:34, 10 February 2024
  • ...'beta-agonists''') are "drugs that selectively bind to and activate beta-[[adrenergic receptor]]s."<ref>{{MeSH}}</ref>
    9 KB (1,175 words) - 14:01, 29 April 2010
  • ...WH, Pei D, Hsiung CA, Chiang FT et al.| title=A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. | journal=Am J Hum Genet | year= 200
    6 KB (877 words) - 07:39, 7 September 2011
  • {{main|Adrenergic receptor}}
    12 KB (1,572 words) - 08:41, 15 July 2010
  • ...Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS et al.| title=beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled relea
    7 KB (1,032 words) - 13:16, 2 February 2023
  • Among [[alpha adrenergic receptor agonist]]s, [[pseudoephedrine]] may be better than [[phenylephrine]] in the
    8 KB (1,068 words) - 07:20, 29 April 2011
  • ...' ('''beta-blockers''') are "drugs that bind to but do not activate beta-[[adrenergic receptor]]s thereby blocking the actions of beta-adrenergic agonists. Adrenergic bet ...sympathomimetic activity (ISA), low membrane stabilizing activity, high [[Adrenergic receptor|beta 1-selectivity]], and high lipophilicity may be more effective.<ref nam
    36 KB (4,786 words) - 23:10, 12 October 2011
  • ...3">{{cite journal |author=Zaugg M, Bestmann L, Wacker J, ''et al.'' |title=Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascu # BBSA noted more [[drug toxicity]] among patients with abnormal beta1-[[adrenergic receptor]] [[genetic polymorphism]]s.<ref name="pmid17585213"/>
    21 KB (2,642 words) - 17:32, 10 February 2024
  • ...sulosin]] due to more selectivity to α<sub>1</sub>-A and α<sub>1</sub>-D [[adrenergic receptor]]s according to a [[meta-analysis]] supported by [[Boehringer Ingelheim Pha
    16 KB (2,300 words) - 11:19, 5 April 2012
  • ...01) Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Que´bec Family Study International Journal
    22 KB (3,507 words) - 09:44, 1 December 2013
  • ...4 }} </ref>. [[Single-nucleotide polymorphism]]s of the ADBR2 subtype of [[adrenergic receptor]] may affect response to [[adrenergic beta-agonist]]s. According to a [[met
    23 KB (3,192 words) - 11:50, 2 February 2023
  • ...">Liggett, Stephen B et al. 2008. A GRK5 polymorphism that inhibits [beta]-adrenergic receptor signaling is protective in heart failure. Nat Med advanced online publicati
    73 KB (10,150 words) - 21:46, 20 August 2014
  • * [[Adrenergic receptor]]
    25 KB (3,396 words) - 13:29, 2 April 2024
  • ...13">{{cite journal |author=Zaugg M, Bestmann L, Wacker J, ''et al'' |title=Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascu
    81 KB (10,863 words) - 17:35, 10 February 2024